广西医学
廣西醫學
엄서의학
GUANGXI MEDICAL JOURNAL
2013年
8期
976-979,983
,共5页
李健%邬国斌%黄盛鑫%黄山%吴飞翔%刘剑勇%黎乐群%赵荫农
李健%鄔國斌%黃盛鑫%黃山%吳飛翔%劉劍勇%黎樂群%趙蔭農
리건%오국빈%황성흠%황산%오비상%류검용%려악군%조음농
肝细胞癌%细胞凋亡%索拉非尼%HBx蛋白%绿色荧光蛋白
肝細胞癌%細胞凋亡%索拉非尼%HBx蛋白%綠色熒光蛋白
간세포암%세포조망%색랍비니%HBx단백%록색형광단백
Hepatocellar carcinoma%Apoptosis%Sorafenib%HBx protein%Green fluorescent protein
目的探讨乙肝病毒HBx蛋白对索拉非尼诱导的肝癌细胞凋亡的影响。方法将空载质粒pEGFP-N1、目的质粒pEGFP-N1-HBx扩增,转染HepG 2细胞,G418筛选抗性克隆,并用RT-PCR检测细胞中HBx表达以表明建立稳定表达细胞株HepG 2/GFP-HBx。用索拉非尼(5μmol/L)分别处理HepG 2、HepG 2/GFP、HepG 2/GFP-HBx细胞,CCK-8计算不同时间点的抑制率;流式细胞检测处理48 h后凋亡率。结果 pEG-FP-N1-HBx经PCR验证扩增成功,RT-PCR显示HepG 2/GFP-HBx细胞有HBx基因转录表达。 CCK-8表明索拉非尼处理的3组细胞均发生了明显的时间依赖性细胞凋亡,流式细胞检测显示索拉非尼处理48 h后,HepG 2、HepG 2/GFP细胞凋亡率分别为32.76%、32.80%明显高于HepG 2/GFP-HBx(16.92%)(P<0.01);未处理组细胞凋亡率为3.72%、4.40%、3.85%,组间比较差异无统计学意义(P>0.05)。结论成功建立了稳定表达GFP、GFP-HBx的HepG 2细胞模型;HBx能够抑制索拉非尼诱导的HepG 2细胞凋亡。
目的探討乙肝病毒HBx蛋白對索拉非尼誘導的肝癌細胞凋亡的影響。方法將空載質粒pEGFP-N1、目的質粒pEGFP-N1-HBx擴增,轉染HepG 2細胞,G418篩選抗性剋隆,併用RT-PCR檢測細胞中HBx錶達以錶明建立穩定錶達細胞株HepG 2/GFP-HBx。用索拉非尼(5μmol/L)分彆處理HepG 2、HepG 2/GFP、HepG 2/GFP-HBx細胞,CCK-8計算不同時間點的抑製率;流式細胞檢測處理48 h後凋亡率。結果 pEG-FP-N1-HBx經PCR驗證擴增成功,RT-PCR顯示HepG 2/GFP-HBx細胞有HBx基因轉錄錶達。 CCK-8錶明索拉非尼處理的3組細胞均髮生瞭明顯的時間依賴性細胞凋亡,流式細胞檢測顯示索拉非尼處理48 h後,HepG 2、HepG 2/GFP細胞凋亡率分彆為32.76%、32.80%明顯高于HepG 2/GFP-HBx(16.92%)(P<0.01);未處理組細胞凋亡率為3.72%、4.40%、3.85%,組間比較差異無統計學意義(P>0.05)。結論成功建立瞭穩定錶達GFP、GFP-HBx的HepG 2細胞模型;HBx能夠抑製索拉非尼誘導的HepG 2細胞凋亡。
목적탐토을간병독HBx단백대색랍비니유도적간암세포조망적영향。방법장공재질립pEGFP-N1、목적질립pEGFP-N1-HBx확증,전염HepG 2세포,G418사선항성극륭,병용RT-PCR검측세포중HBx표체이표명건립은정표체세포주HepG 2/GFP-HBx。용색랍비니(5μmol/L)분별처리HepG 2、HepG 2/GFP、HepG 2/GFP-HBx세포,CCK-8계산불동시간점적억제솔;류식세포검측처리48 h후조망솔。결과 pEG-FP-N1-HBx경PCR험증확증성공,RT-PCR현시HepG 2/GFP-HBx세포유HBx기인전록표체。 CCK-8표명색랍비니처리적3조세포균발생료명현적시간의뢰성세포조망,류식세포검측현시색랍비니처리48 h후,HepG 2、HepG 2/GFP세포조망솔분별위32.76%、32.80%명현고우HepG 2/GFP-HBx(16.92%)(P<0.01);미처리조세포조망솔위3.72%、4.40%、3.85%,조간비교차이무통계학의의(P>0.05)。결론성공건립료은정표체GFP、GFP-HBx적HepG 2세포모형;HBx능구억제색랍비니유도적HepG 2세포조망。
Objective To investigate the effect of hepatitis B virus X ( HBx) protein on sorafenib-induced ap-optosis of hepatocellar carcinoma cells .Methods The pEGFP-N1 and pEGFP-N1-HBx were amplified ,HepG2 cells were transfected ,and the positive cell clone was selected by using G 418 .Reverse transcription polymerase chain reac-tion(RT-PCR) was used to detect the expression of HBx gene for demonstration of stable expression of cell line HepG2/GFP-HBx.HepG2,HepG2/GFP and HepG2/GFP-HBx cells were treated with sorafenib (5μmol/l) respec-tively ,the inhibition rates of the cells at different time points were tested by CCK-8;Flow cytometry was used to test the apoptosis rates of the cells 48 hours after incubation .Results The recombinant plasmid pEGFP-N1-HBx was ver-ified to contain HBx by PCR amplification .The HBx expression was detected by RT-PCR.CCK-8 showed that sor-afenib induced significant time-dependent cell apoptosis in HepG2,HepG2/GFP and HepG2/GFP-HBx cells.Flow cytometry showed that the apoptosis rates in HepG2(32.76%),HepG2/GFP(32.80%) cells were significantly high-er than that in HepG2/GFP-HBx cell(16.92%) 48 hours after incubation of sorafenib (P<0.01); The apoptosis rates in untreated cells were 3.72%,4.40%,3.85%,respectively,there was no significant difference among groups (P>0.05).Conclusion The stable-expression HepG2/GFP and HepG2/GFP-HBx cell models are established suc-cessfully;HBx protein can suppress sorafenib-induced apoptosis of HepG2 cells.